Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
Authors
Keywords
-
Journal
Experimental Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-11
DOI
10.1186/s40164-022-00352-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deglycosylated EpCAM regulates proliferation by enhancing autophagy of breast cancer cells via PI3K/Akt/mTOR pathway
- (2022) Liu Yang et al. Aging-US
- Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
- (2022) Alba Rodriguez-Martinez et al. Theranostics
- Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
- (2022) Xinlin Liu et al. PHARMACOLOGY & THERAPEUTICS
- Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis
- (2022) Zhenzhen Han et al. BIOSENSORS & BIOELECTRONICS
- EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
- (2021) Arijit Mal et al. Frontiers in Cell and Developmental Biology
- A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma
- (2021) Victor M. Baart et al. EUROPEAN JOURNAL OF CANCER
- Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
- (2021) Mustafa Karabicici et al. Molecular Oncology
- Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
- (2021) Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase
- (2021) Marco Fiorillo et al. CELL DEATH AND DIFFERENTIATION
- EpCam is Required for Maintaining the Integrity of the Biliary Epithelium
- (2021) Yougen Zhan et al. LIVER INTERNATIONAL
- Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis
- (2021) Marco Trerotola et al. NEOPLASIA
- Rapamycin pretreatment rescues the bone marrow AML cell elimination capacity of CAR-T cells
- (2021) Zhigang Nian et al. CLINICAL CANCER RESEARCH
- Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency
- (2021) Khadijeh Barzaman et al. EXPERIMENTAL CELL RESEARCH
- Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells
- (2021) Jiřina Hofmanová et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
- (2021) Minggang Zhang et al. Science Translational Medicine
- Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor
- (2021) Yan Liu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses
- (2021) Yanping Yang et al. Cancer Immunology Research
- Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles
- (2021) Emily M. Ploeg et al. CANCER LETTERS
- Trop2 Forms a Stable Dimer with Significant Structural Differences within the Membrane-Distal Region as Compared to EpCAM
- (2021) Miha Pavšič INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
- (2021) Shin Yi Tang et al. Stem Cell Research & Therapy
- Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
- (2021) Weizhen Li et al. Frontiers in Pharmacology
- CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
- (2021) Guillaume Belthier et al. Cancers
- MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
- (2020) Laura Gramantieri et al. CANCER RESEARCH
- Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
- (2020) Joseph C Ahn et al. HEPATOLOGY
- The heparan sulfate proteoglycan syndecan‐1 regulates colon cancer stem cell function via a focal adhesion kinase—Wnt signaling axis
- (2020) Sampath Kumar Katakam et al. FEBS Journal
- Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition
- (2020) Heena Jariyal et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
- (2020) Dong Jun Park et al. Journal for ImmunoTherapy of Cancer
- Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins
- (2020) Chuan-Jin Wu et al. Cells
- Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma
- (2020) Leili Saeednejad Zanjani et al. Annals of Diagnostic Pathology
- EpCAM signaling promotes tumor progression and protein stability of PD-L1 through the EGFR pathway
- (2020) Hao-Nien Chen et al. CANCER RESEARCH
- Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation
- (2020) Abu Shadat M. Noman et al. Cell Death & Disease
- Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
- (2020) Elena Shramova et al. Cancers
- EpCAM cellular functions in adhesion and migration, and potential impact on invasion: A critical review
- (2020) François Fagotto et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer
- (2020) Ruizan Shi et al. CELLULAR SIGNALLING
- Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression
- (2020) Yuan Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
- (2020) May Daher et al. Cancer Discovery
- Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain
- (2019) Yuanchi Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer
- (2019) Wei Zhao et al. Cancer Medicine
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
- (2019) Jessica B. Casaletto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma
- (2019) Atsushi Takai et al. CANCER RESEARCH
- The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR–LIN28–LET7 signaling
- (2019) I.-I. Kuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application
- (2019) Xiaowen Ma et al. MOLECULAR PHARMACEUTICS
- Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines
- (2019) Tataranni et al. Cells
- Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
- (2019) Kaoru Onidani et al. CANCER SCIENCE
- miR‐26b‐5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC
- (2019) Ritu Khosla et al. LIVER INTERNATIONAL
- Immunocyte Profiling Using Single-Cell Mass Cytometry Reveals EpCAM+ CD4+ T Cells Abnormal in Colon Cancer
- (2019) Ting Zhang et al. Frontiers in Immunology
- Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer
- (2019) Daniel Wai-Hung Ho et al. CANCER LETTERS
- Profiling of Exosomal Biomarkers for Accurate Cancer Identification: Combining DNA‐PAINT with Machine‐ Learning‐Based Classification
- (2019) Chen Chen et al. Small
- Hypoxia modulates stem cell properties and induces EMT through N ‐glycosylation of EpCAM in breast cancer cells
- (2019) Dandan Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p
- (2019) Ke-shuai Dong et al. ONCOGENE
- LncRNATCF7 promotes the growth and self-renewal of glioma cells via suppressing the miR-200c-EpCAM axis
- (2018) Jian Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Quantified postsurgical small cell size CTCs and EpCAM + circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse
- (2018) Liang Wang et al. CANCER LETTERS
- Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells
- (2018) Kang-Hao Liang et al. CANCER LETTERS
- Antibody based EpCAM targeted Therapy of Cancer, Review and update
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma
- (2018) Kuo-Chang Wen et al. GYNECOLOGIC ONCOLOGY
- A Novel Multimarker Assay for the Phenotypic Profiling of Circulating Tumor Cells in Hepatocellular Carcinoma
- (2018) Colin M. Court et al. LIVER TRANSPLANTATION
- Extracellular vesicles in cancer — implications for future improvements in cancer care
- (2018) Rong Xu et al. Nature Reviews Clinical Oncology
- Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
- (2018) Md Zahid Akhter et al. ONCOGENE
- Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway
- (2018) Meng-He Wang et al. Cell Death & Disease
- EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
- (2018) Joanna Macdonald et al. Cancers
- Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells
- (2018) Xue Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Regulation of epithelial migration by epithelial cell adhesion molecule requires its Claudin-7 interaction domain
- (2018) Angela I. M. Barth et al. PLoS One
- EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion
- (2018) Aljaž Gaber et al. Scientific Reports
- EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
- (2018) Min Pan et al. PLOS BIOLOGY
- Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
- (2018) Jie Ni et al. BMC CANCER
- NK cell-derived IFN-γ promotes hepatocellular carcinoma through EpCAM-EMT axis in hepatitis B virus transgenic mice
- (2018) Yongyan Chen et al. HEPATOLOGY
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway
- (2018) Zhangjun Cheng et al. GENE
- Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis
- (2017) Chuan-Jin Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter
- (2017) Jia Ding et al. LABORATORY INVESTIGATION
- A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial–mesenchymal transition in cancer
- (2017) N V Sankpal et al. ONCOGENE
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients
- (2017) Ritu Khosla et al. Stem Cells Translational Medicine
- EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α
- (2017) I.-I. Kuan et al. Scientific Reports
- p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling
- (2016) Nikhil Tyagi et al. CANCER LETTERS
- EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance
- (2016) Xiaohu Zheng et al. CANCER RESEARCH
- Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity
- (2016) Sheng-Chieh Lin et al. CANCER RESEARCH
- EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition
- (2016) Ya-Ting Hsu et al. CANCER RESEARCH
- Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
- (2016) Xue Wang et al. JOURNAL OF HEPATOLOGY
- Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization
- (2016) Hyungjin Rhee et al. MODERN PATHOLOGY
- A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
- (2016) M. L. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
- (2016) Joerg U Schmohl et al. MOLECULAR THERAPY
- Nuclear EpICD expression and its role in hepatocellular carcinoma
- (2016) SHIN YOUNG PARK et al. ONCOLOGY REPORTS
- EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance
- (2016) Lingling Jiang et al. Nature Communications
- EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration
- (2015) Qianlan Fan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus–Induced Liver Carcinogenesis
- (2015) Hao Zhang et al. CANCER RESEARCH
- βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin
- (2015) Xiuling Zhi et al. HEPATOLOGY
- Cleavage and Cell Adhesion Properties of Human Epithelial Cell Adhesion Molecule (HEPCAM)
- (2015) Thanos Tsaktanis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro
- (2015) Francesca Ferrari et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interrogating Circulating Microsomes and Exosomes Using Metal Nanoparticles
- (2015) Yi-Ge Zhou et al. Small
- The detection of EpCAM+ and EpCAM– circulating tumor cells
- (2015) Sanne de Wit et al. Scientific Reports
- EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
- (2015) Helen Schneck et al. PLoS One
- The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study
- (2014) M. M. Heiss et al. CLINICAL CANCER RESEARCH
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway
- (2014) Z.J. LIAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by AP1-Dependent EpCAM Expression in MCF-7 Cells
- (2014) Jiujiao Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
- (2014) Hannah Woopen et al. Journal of Gynecologic Oncology
- E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling
- (2014) C Eberlein et al. ONCOGENE
- Crystal structure and its bearing towards an understanding of key biological functions of EpCAM
- (2014) Miha Pavšič et al. Nature Communications
- A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
- (2013) Joseph P Connor et al. BMC CANCER
- Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
- (2013) V S Warneke et al. BRITISH JOURNAL OF CANCER
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression
- (2013) Pengfei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Trop-2 Promotes Prostate Cancer Metastasis By Modulating 1 Integrin Functions
- (2013) M. Trerotola et al. CANCER RESEARCH
- Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer
- (2013) Y.-T. Hsu et al. CLINICAL CANCER RESEARCH
- EpCAM Controls Actomyosin Contractility and Cell Adhesion by Direct Inhibition of PKC
- (2013) Nadim Maghzal et al. DEVELOPMENTAL CELL
- Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
- (2013) Jie Ni et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Epithelial Cell Adhesion Molecule (EpCAM) Regulates Claudin Dynamics and Tight Junctions
- (2013) Chuan-Jin Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth
- (2013) Agnieszka Martowicz et al. Molecular Cancer
- EpCAM Modulates NF-κB Signaling and Interleukin-8 Expression in Breast Cancer
- (2013) Narendra V. Sankpal et al. MOLECULAR CANCER RESEARCH
- Context-dependent adaption of EpCAM expression in early systemic esophageal cancer
- (2013) C Driemel et al. ONCOGENE
- Regulated Intramembrane Proteolysis and Degradation of Murine Epithelial Cell Adhesion Molecule mEpCAM
- (2013) Matthias Hachmeister et al. PLoS One
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
- (2012) M. Schmidt et al. ANNALS OF ONCOLOGY
- EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins
- (2012) Zili Lei et al. DEVELOPMENTAL BIOLOGY
- Catumaxomab
- (2012) James E. Frampton DRUGS
- Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via -catenin signaling
- (2012) T. Stoyanova et al. GENES & DEVELOPMENT
- Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer
- (2012) Cheng-Wei Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma
- (2012) Gerhard Moldenhauer et al. JNCI-Journal of the National Cancer Institute
- EpCAM regulates cell cycle progression via control of cyclin D1 expression
- (2012) A Chaves-Pérez et al. ONCOGENE
- Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells
- (2011) Takeshi Motohara et al. CARCINOGENESIS
- EpCAM/CD3-Bispecific T-cell Engaging Antibody MT110 Eliminates Primary Human Pancreatic Cancer Stem Cells
- (2011) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming
- (2011) Hsiang-Po Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
- (2010) Ranju Ralhan et al. BMC CANCER
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status
- (2010) Yun-feng Shan et al. MEDICAL ONCOLOGY
- Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
- (2010) Norbert Marschner et al. UROLOGIA INTERNATIONALIS
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- Initial activation of EpCAM cleavage viacell-to-cell contact
- (2009) Sabine Denzel et al. BMC CANCER
- Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration
- (2009) Jennifer Brown et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion
- (2009) N. V. Sankpal et al. CANCER RESEARCH
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma
- (2009) E. E. Johnson et al. CLINICAL CANCER RESEARCH
- Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
- (2009) Jeannick Cizeau et al. JOURNAL OF IMMUNOTHERAPY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Characterization of Epithelial Cell Adhesion Molecule as a Surface Marker on Undifferentiated Human Embryonic Stem Cells
- (2009) Valerie Y. Ng et al. STEM CELLS
- Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
- (2008) Markus Munz Frontiers in Bioscience-Landmark
- Identification of EpCAM as the Gene for Congenital Tufting Enteropathy
- (2008) Mamata Sivagnanam et al. GASTROENTEROLOGY
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now